Emcure PharmaceuticalsNSE:EMCURE +0.27%41 Dividend Payout Ratio is 0.00 as of Mar. 2026. GuruFocus rates NSE:EMCURE with a GF Score™ of 41/100. The stock has 5 warning signs investors should review. Among 445 Drug Manufacturers companies, Emcure Pharmaceuticals ranks better than 95.96% on this metric.
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Emcure Pharmaceuticals's Dividend Payout Ratio for the
months ended in Mar. 2026 was 0.00.
The historical rank and industry rank for Emcure Pharmaceuticals's Dividend Payout Ratio or its related term are showing as below:
NSE:EMCURE'
s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.06 Med: 0.06 Max: 0.06
Current: 0.06
During the past 6 years, the highest Dividend Payout Ratio of Emcure Pharmaceuticals was 0.06. The lowest was 0.06. And the median was 0.06.
NSE:EMCURE's Dividend Payout Ratio is ranked better than 95.96% of 445
companies
in the Drug Manufacturers industry
Industry Median: 0.38
vs NSE:EMCURE: 0.06
During the past 6 years, the highest Trailing Annual Dividend Yield of Emcure Pharmaceuticals was 0.23%. The lowest was 0.16%. And the median was 0.20%.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Emcure Pharmaceuticals (NSE:EMCURE) Dividend Payout Ratio Explanation
In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Emcure Pharmaceuticals Dividend Payout Ratio Related Terms
Emcure Pharmaceuticals Dividend Payout Ratio Historical Data
* Premium members only.
The historical data trend for Emcure Pharmaceuticals's Dividend Payout Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Emcure Pharmaceuticals Dividend Payout Ratio Chart
NSE:EMCURE vs ZTS, UTHR: Dividend Payout Ratio Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Emcure Pharmaceuticals's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Emcure Pharmaceuticals Dividend Payout Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Emcure Pharmaceuticals's Dividend Payout Ratio distribution charts can be found below:
* The bar in red indicates where Emcure Pharmaceuticals's Dividend Payout Ratio falls into.
Emcure Pharmaceuticals Dividend Payout Ratio Calculation
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.
Emcure Pharmaceuticals's Dividend Payout Ratio for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Emcure Pharmaceuticals (NSE:EMCURE) has a Dividend Payout Ratio of 0.00 as of Mar. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Emcure Pharmaceuticals and its competitors. Over the past decade, Emcure Pharmaceuticals' Dividend Payout Ratio has ranged from 0.06 to 0.06. According to the industry distribution chart, Emcure Pharmaceuticals ranks #18 out of 445 companies in the Drug Manufacturers industry, placing it in the top 4%.
Is Emcure Pharmaceuticals' Dividend Payout Ratio too high?
Emcure Pharmaceuticals' current Dividend Payout Ratio is 0.00. Over the past 10 years, this metric has ranged from a low of 0.06 to a high of 0.06. Based on the distribution chart, Emcure Pharmaceuticals ranks #18 out of 445 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Emcure Pharmaceuticals has a GF Score™ of 41/100, reflecting its overall financial health beyond just this single metric.
How does Emcure Pharmaceuticals' Dividend Payout Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Emcure Pharmaceuticals ranks #18 out of 445 companies for Dividend Payout Ratio. This places Emcure Pharmaceuticals in the top 4% of its industry — outperforming the majority of peers. The industry median Dividend Payout Ratio is 0.38. Historically, Emcure Pharmaceuticals' own Dividend Payout Ratio has ranged from 0.06 to 0.06 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Drug Manufacturers company?
The median Dividend Payout Ratio among Drug Manufacturers companies is 0.38, based on 445 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Emcure Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median Dividend Payout Ratio is 0.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Emcure Pharmaceuticals's current Dividend Payout Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Emcure Pharmaceuticals stock overvalued right now?
Emcure Pharmaceuticals (NSE:EMCURE) has a current Dividend Payout Ratio of 0.00. The current Dividend Payout Ratio is 0.00. Emcure Pharmaceuticals' overall GF Score™ is 41/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Emcure Pharmaceuticals (NSE:EMCURE), the current Dividend Payout Ratio is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Emcure Pharmaceuticals Ltd an Indian pharmaceutical company engaged in developing, manufacturing and globally marketing a range of pharmaceutical products across several therapeutic areas. Its portfolio includes orals including solids, liquid orals and dry syrup/suspensions., injectables such as vials and pre-filled syringes, and forms such as lyophilized & liquid and biotherapeutics. The company operates in Derma, Women's Health, Cardiovascular, Neurology, Oncology, Vaccines, and Anti-infectives. Geographically, it operates in India, Europe, Canada, Vietnam, Dubai, and Other Countries.
41GF Score
Get the complete analysis for NSE:EMCURE
Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:EMCURE has been successfully added to your 
